Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Neurotoxicol Teratol
2008 Jan 01;306:503-9. doi: 10.1016/j.ntt.2008.05.003.
Show Gene links
Show Anatomy links
Amyloid precursor protein 96-110 and beta-amyloid 1-42 elicit developmental anomalies in sea urchin embryos and larvae that are alleviated by neurotransmitter analogs for acetylcholine, serotonin and cannabinoids.
Buznikov GA
,
Nikitina LA
,
Seidler FJ
,
Slotkin TA
,
Bezuglov VV
,
Milosević I
,
Lazarević L
,
Rogac L
,
Ruzdijić S
,
Rakić LM
.
Abstract
Amyloid precursor protein (APP) is overexpressed in the developing brain and portions of its extracellular domain, especially amino acid residues 96-110, play an important role in neurite outgrowth and neural cell differentiation. In the current study, we evaluated the developmental abnormalities caused by administration of exogenous APP(96-110) in sea urchin embryos and larvae, which, like the developing mammalian brain, utilize acetylcholine and other neurotransmitters as morphogens; effects were compared to those of beta-amyloid 1-42 (Abeta42), the neurotoxic APP fragment contained within neurodegenerative plaques in Alzheimer''s Disease. Although both peptides elicited dysmorphogenesis, Abeta42 was far more potent; in addition, whereas Abeta42 produced abnormalities at developmental stages ranging from early cleavage divisions to the late pluteus, APP(96-110) effects were restricted to the intermediate, mid-blastula stage. For both agents, anomalies were prevented or reduced by addition of lipid-permeable analogs of acetylcholine, serotonin or cannabinoids; physostigmine, a carbamate-derived cholinesterase inhibitor, was also effective. In contrast, agents that act on NMDA receptors (memantine) or alpha-adrenergic receptors (nicergoline), and that are therapeutic in Alzheimer''s Disease, were themselves embryotoxic, as was tacrine, a cholinesterase inhibitor from a different chemical class than physostigmine. Protection was also provided by agents acting downstream from receptor-mediated events: increasing cyclic AMP with caffeine or isobutylmethylxanthine, or administering the antioxidant, a-tocopherol, were all partially effective. Our findings reinforce a role for APP in development and point to specific interactions with neurotransmitter systems that act as morphogens in developing sea urchins as well as in the mammalian brain.
Bezuglov,
[Artificially functionalized polyenoic fatty acids--a new lipid bioregulators].
1997,
Pubmed
,
Echinobase
Brimijoin,
Cholinesterases in neural development: new findings and toxicologic implications.
1999,
Pubmed
Buznikov,
The sea urchin embryo, an invertebrate model for mammalian developmental neurotoxicity, reveals multiple neurotransmitter mechanisms for effects of chlorpyrifos: therapeutic interventions and a comparison with the monoamine depleter, reserpine.
2007,
Pubmed
,
Echinobase
Buznikov,
The pre-nervous serotonergic system of developing sea urchin embryos and larvae: pharmacologic and immunocytochemical evidence.
2005,
Pubmed
,
Echinobase
Buznikov,
From oocyte to neuron: do neurotransmitters function in the same way throughout development?
1996,
Pubmed
Buznikov,
Sea urchin embryos and larvae as biosensors for neurotoxicants.
2003,
Pubmed
,
Echinobase
Buznikov,
[Polyenic acid 5-hydroxytryptamides and 3-hydroxytyramides as tools for studying of the pre-nervous biogenic monoamine functions].
2000,
Pubmed
,
Echinobase
Buznikov,
Cholinoreceptors of early (preneural) sea urchin embryos.
2000,
Pubmed
,
Echinobase
Buznikov,
An invertebrate model of the developmental neurotoxicity of insecticides: effects of chlorpyrifos and dieldrin in sea urchin embryos and larvae.
2001,
Pubmed
,
Echinobase
Buznikov,
[Cholinergic regulation of the sea urchin embryonic and larval development].
2001,
Pubmed
,
Echinobase
Buznikov,
Sea urchin embryonic development provides a model for evaluating therapies against beta-amyloid toxicity.
2008,
Pubmed
,
Echinobase
Buznikov,
The role of neurohumors in early embryogenesis. II. Acetylcholine and catecholamine content in developing embryos of sea urchin.
1968,
Pubmed
,
Echinobase
Buznikov,
The role of neurohumours in early embryogenesis. 3. Pharmacological analysis of the role of neurohumours in cleavage divisions.
1970,
Pubmed
Carrotta,
Toxicity of recombinant beta-amyloid prefibrillar oligomers on the morphogenesis of the sea urchin Paracentrotus lividus.
2006,
Pubmed
,
Echinobase
Casida,
Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets.
2004,
Pubmed
Crowther,
A Drosophila model of Alzheimer's disease.
2006,
Pubmed
Day,
A non-cholinergic, trophic action of acetylcholinesterase on hippocampal neurones in vitro: molecular mechanisms.
2002,
Pubmed
Esposito,
CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons.
2006,
Pubmed
Gralle,
Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts.
2007,
Pubmed
Gustafson,
On the role of serotonin and acetylcholine in sea urchin morphogenesis.
1970,
Pubmed
,
Echinobase
Hagström,
The sea urchin egg as a testing object in toxicology.
1973,
Pubmed
,
Echinobase
Hohmann,
A morphogenetic role for acetylcholine in mouse cerebral neocortex.
2003,
Pubmed
Katz,
Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities.
1997,
Pubmed
Kidd,
Effects of amyloid peptides on A-type K+ currents of Drosophila larval cholinergic neurons.
2006,
Pubmed
Koenigsberger,
Neurite differentiation is modulated in neuroblastoma cells engineered for altered acetylcholinesterase expression.
1997,
Pubmed
Lauder,
Morphogenetic roles of acetylcholine.
1999,
Pubmed
Link,
C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
2006,
Pubmed
Nallapaneni,
Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2.
2006,
Pubmed
Priller,
Synapse formation and function is modulated by the amyloid precursor protein.
2006,
Pubmed
Qiao,
The sea urchin embryo as a model for mammalian developmental neurotoxicity: ontogenesis of the high-affinity choline transporter and its role in cholinergic trophic activity.
2003,
Pubmed
,
Echinobase
Reinhard,
The amyloid-beta precursor protein: integrating structure with biological function.
2005,
Pubmed
Scatena,
An update on pharmacological approaches to neurodegenerative diseases.
2007,
Pubmed
Serretti,
Genes involved in Alzheimer's disease, a survey of possible candidates.
2005,
Pubmed
Shmukier,
Functional coupling of neurotransmitters with second messengers during cleavage divisions: facts and hypotheses.
1998,
Pubmed
Slotkin,
Ameliorating the developmental neurotoxicity of chlorpyrifos: a mechanisms-based approach in PC12 cells.
2007,
Pubmed
Small,
Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease.
2002,
Pubmed
Small,
A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth.
1994,
Pubmed
Smulders,
Block of neuronal nicotinic acetylcholine receptors by organophosphate insecticides.
2004,
Pubmed
Sodergren,
The genome of the sea urchin Strongylocentrotus purpuratus.
2006,
Pubmed
,
Echinobase
Sternfeld,
Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini.
1998,
Pubmed
Turner,
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.
2003,
Pubmed
Vallano,
Developmental aspects of NMDA receptor function.
1998,
Pubmed
Wu,
Transgenic C. elegans as a model in Alzheimer's research.
2005,
Pubmed
Yanai,
Cell signaling as a target and underlying mechanism for neurobehavioral teratogenesis.
2002,
Pubmed
Young-Pearse,
A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference.
2007,
Pubmed
Zagon,
Opioid growth factor and organ development in rat and human embryos.
1999,
Pubmed
Zagon,
Gene expression of OGFr in the developing and adult rat brain and cerebellum.
2004,
Pubmed
Zamani,
Nicotine and its interaction with beta-amyloid protein: a short review.
2001,
Pubmed
